Skip to main content
Top
Published in: Journal of Clinical Immunology 5/2023

Open Access 09-03-2023 | Necrotizing Fasciitis | Original Article

Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis

Authors: Wenny Santaniemi, Pirjo Åström, Virpi Glumoff, Nora Pernaa, Ella-Noora Tallgren, Sanna Palosaari, Antti Nissinen, Meri Kaustio, Outi Kuismin, Janna Saarela, Katariina Nurmi, Kari K. Eklund, Mikko R. J. Seppänen, Timo Hautala

Published in: Journal of Clinical Immunology | Issue 5/2023

Login to get access

Abstract

Loss-of-function (LOF) mutations in NFKB1, coding for p105, may cause common variable immunodeficiency due to dysregulation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κΒ) pathway. Monoallelic LOF variants of NFKB1 can predispose to uncontrolled inflammation including sterile necrotizing fasciitis or pyoderma gangrenosum. In this study, we explored the impact of a heterozygous NFKB1 c.C936T/p.R157X LOF variant on immunity in sterile fasciitis patients and their family members. The p50 or p105 protein levels were reduced in all variant carriers. Interleukin-1β (IL-1β) and interleukin-8 (IL-8) levels were elevated in vitro, potentially contributing to the very high neutrophil counts observed during fasciitis episodes. Phosphorylation of p65/RelA was reduced in p.R157X neutrophils suggesting defective activation of canonical NF-κB. Oxidative burst after NF-κB-independent phorbol 12-myristate 13-acetate (PMA) stimulation was similar in both p.R157X and control neutrophils. Comparable amounts of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex subunits were found in p.R157X and control neutrophils. However, a compromised oxidative burst was observed in p.R157X neutrophils following activation of NF-κB-dependent mechanisms following stimulation of toll-like receptor 2 (TLR2) and Dectin-1. Neutrophil extracellular trap formation was not affected by p.R157X. In summary, the NFKB1 c.C936T/p.R157X LOF variant has an impact on inflammation and neutrophil function and may play a role in the pathogenesis of sterile necrotizing fasciitis.
Appendix
Available only for authorised users
Literature
3.
go back to reference Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399.CrossRefPubMedPubMedCentral Aksentijevich I, Zhou Q. NF-κB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol. 2017;8:399.CrossRefPubMedPubMedCentral
4.
go back to reference Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85.CrossRefPubMedPubMedCentral Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85.CrossRefPubMedPubMedCentral
6.
go back to reference Gauss KA, Nelson-Overton LK, Siemsen DW, Gao Y, DeLeo FR, Quinn MT. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol. 2007;82:729–41.CrossRefPubMed Gauss KA, Nelson-Overton LK, Siemsen DW, Gao Y, DeLeo FR, Quinn MT. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol. 2007;82:729–41.CrossRefPubMed
7.
go back to reference von Vietinghoff S, Asagiri M, Azar D, Hoffmann A, Ley K. Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice. J Immunol. 2010;185:670–8.CrossRef von Vietinghoff S, Asagiri M, Azar D, Hoffmann A, Ley K. Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice. J Immunol. 2010;185:670–8.CrossRef
8.
go back to reference Navarini AA, Satoh TK, French LE. Neutrophilic dermatoses and autoinflammatory diseases with skin involvement–innate immune disorders. Semin Immunopathol. 2016;38:45–56.CrossRefPubMed Navarini AA, Satoh TK, French LE. Neutrophilic dermatoses and autoinflammatory diseases with skin involvement–innate immune disorders. Semin Immunopathol. 2016;38:45–56.CrossRefPubMed
9.
go back to reference Marzano AV, Ortega-Loayza AG, Heath M, Morse D, Genovese G, Cugno M. Mechanisms of inflammation in neutrophil-mediated skin diseases. Front Immunol. 2019;10:1059.CrossRefPubMedPubMedCentral Marzano AV, Ortega-Loayza AG, Heath M, Morse D, Genovese G, Cugno M. Mechanisms of inflammation in neutrophil-mediated skin diseases. Front Immunol. 2019;10:1059.CrossRefPubMedPubMedCentral
11.
go back to reference Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol. 2018;142:1285–96.CrossRefPubMedPubMedCentral Tuijnenburg P, Lango Allen H, Burns SO, Greene D, Jansen MH, Staples E, et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol. 2018;142:1285–96.CrossRefPubMedPubMedCentral
12.
go back to reference Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, et al. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020;146:901–11.CrossRefPubMedPubMedCentral Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, et al. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020;146:901–11.CrossRefPubMedPubMedCentral
13.
go back to reference Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140:782–96.CrossRefPubMed Kaustio M, Haapaniemi E, Göös H, Hautala T, Park G, Syrjänen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140:782–96.CrossRefPubMed
14.
go back to reference Fang R, Wang J, Jiang X-Y, Wang S-H, Cheng H, Zhou Q. Case report: a novel mutation in associated with pyoderma gangrenosum. Front Genet. 2021;12:673453.CrossRefPubMedPubMedCentral Fang R, Wang J, Jiang X-Y, Wang S-H, Cheng H, Zhou Q. Case report: a novel mutation in associated with pyoderma gangrenosum. Front Genet. 2021;12:673453.CrossRefPubMedPubMedCentral
16.
go back to reference Bergbreiter A, Jaeger T, Karle A, Bitzinger D, Ettl T, Spanier G, et al. Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation. Eur J Med Genet. 2021;64:104144.CrossRefPubMed Bergbreiter A, Jaeger T, Karle A, Bitzinger D, Ettl T, Spanier G, et al. Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation. Eur J Med Genet. 2021;64:104144.CrossRefPubMed
18.
go back to reference Lilius E-ME, Nuutila JTJ. Particle-induced myeloperoxidase release in serially diluted whole blood quantifies the number and the phagocytic activity of blood neutrophils and opsonization capacity of plasma. Luminescence. 2006;21:148–58.CrossRefPubMed Lilius E-ME, Nuutila JTJ. Particle-induced myeloperoxidase release in serially diluted whole blood quantifies the number and the phagocytic activity of blood neutrophils and opsonization capacity of plasma. Luminescence. 2006;21:148–58.CrossRefPubMed
19.
go back to reference Roos D, Boer M. Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol Oxford Academic. 2014;175:139–49.CrossRef Roos D, Boer M. Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol Oxford Academic. 2014;175:139–49.CrossRef
21.
go back to reference Rajamäki K, Keskitalo S, Seppänen M, Kuismin O, Vähäsalo P, Trotta L, et al. Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. RMD Open. 2018;4:e000740.CrossRefPubMedPubMedCentral Rajamäki K, Keskitalo S, Seppänen M, Kuismin O, Vähäsalo P, Trotta L, et al. Haploinsufficiency of A20 impairs protein-protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. RMD Open. 2018;4:e000740.CrossRefPubMedPubMedCentral
22.
go back to reference Li J, Lei W-T, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, et al. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency. J Exp Med. 2021;218:e20210566.CrossRefPubMedPubMedCentral Li J, Lei W-T, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, et al. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency. J Exp Med. 2021;218:e20210566.CrossRefPubMedPubMedCentral
24.
go back to reference Kim G-Y, Lee J-W, Ryu H-C, Wei J-D, Seong C-M, Kim J-H. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol. 2010;184:3946–54.CrossRefPubMed Kim G-Y, Lee J-W, Ryu H-C, Wei J-D, Seong C-M, Kim J-H. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis. J Immunol. 2010;184:3946–54.CrossRefPubMed
25.
go back to reference Johansson L, Thulin P, Low DE, Norrby-Teglund A. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis. 2010;51:58–65.CrossRefPubMed Johansson L, Thulin P, Low DE, Norrby-Teglund A. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin Infect Dis. 2010;51:58–65.CrossRefPubMed
26.
go back to reference Wu W, Hsu Y-MS, Bi L, Songyang Z, Lin X. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat Immunol. 2009;10:1208–14.CrossRefPubMed Wu W, Hsu Y-MS, Bi L, Songyang Z, Lin X. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex. Nat Immunol. 2009;10:1208–14.CrossRefPubMed
27.
28.
go back to reference Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE, et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood. 2002;100:1860–8.CrossRefPubMed Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE, et al. Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood. 2002;100:1860–8.CrossRefPubMed
29.
go back to reference Wang X, Zhang R, Wu W, Song Y, Wan Z, Han W, et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol. 2018;138:607–17.CrossRefPubMed Wang X, Zhang R, Wu W, Song Y, Wan Z, Han W, et al. Impaired specific antifungal immunity in CARD9-deficient patients with phaeohyphomycosis. J Invest Dermatol. 2018;138:607–17.CrossRefPubMed
31.
go back to reference Okamura K, Uchida T, Hayashi M, Yaguchi Y, Hemmi A, Murata I, et al. Neutrophilic dermatosis associated with an NFKB2 mutation. Clin Exp Dermatol. 2019;44:350–2.CrossRefPubMed Okamura K, Uchida T, Hayashi M, Yaguchi Y, Hemmi A, Murata I, et al. Neutrophilic dermatosis associated with an NFKB2 mutation. Clin Exp Dermatol. 2019;44:350–2.CrossRefPubMed
32.
go back to reference Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, et al. Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol. 2019;155:79–84.CrossRefPubMed Sanchez IM, Lowenstein S, Johnson KA, Babik J, Haag C, Keller JJ, et al. Clinical features of neutrophilic dermatosis variants resembling necrotizing fasciitis. JAMA Dermatol. 2019;155:79–84.CrossRefPubMed
33.
go back to reference Kaustio M, Hautala T, Seppänen MRJ. Primary Immunodeficiency, a Possible Cause of Neutrophilic Necrotizing Dermatosis. JAMA Dermatol. 2019;155:863–4.CrossRefPubMed Kaustio M, Hautala T, Seppänen MRJ. Primary Immunodeficiency, a Possible Cause of Neutrophilic Necrotizing Dermatosis. JAMA Dermatol. 2019;155:863–4.CrossRefPubMed
34.
go back to reference Dingjan I, Linders PTA, van den Bekerom L, Baranov MV, Halder P, Ter Beest M, et al. Oxidized phagosomal NOX2 complex is replenished from lysosomes. J Cell Sci. 2017;130:1285–98.PubMedPubMedCentral Dingjan I, Linders PTA, van den Bekerom L, Baranov MV, Halder P, Ter Beest M, et al. Oxidized phagosomal NOX2 complex is replenished from lysosomes. J Cell Sci. 2017;130:1285–98.PubMedPubMedCentral
35.
go back to reference Paclet M-H, Laurans S, Dupré-Crochet S. Regulation of neutrophil NADPH oxidase, NOX2: a crucial effector in neutrophil phenotype and function. Front Cell Dev Biol. 2022;10:945749.CrossRefPubMedPubMedCentral Paclet M-H, Laurans S, Dupré-Crochet S. Regulation of neutrophil NADPH oxidase, NOX2: a crucial effector in neutrophil phenotype and function. Front Cell Dev Biol. 2022;10:945749.CrossRefPubMedPubMedCentral
36.
go back to reference Yu H-H, Yang Y-H, Chiang B-L. Chronic granulomatous disease: a comprehensive review. Clin Rev Allergy Immunol. 2021;61:101–13.CrossRefPubMed Yu H-H, Yang Y-H, Chiang B-L. Chronic granulomatous disease: a comprehensive review. Clin Rev Allergy Immunol. 2021;61:101–13.CrossRefPubMed
Metadata
Title
Inflammation and Neutrophil Oxidative Burst in a Family with NFKB1 p.R157X LOF and Sterile Necrotizing Fasciitis
Authors
Wenny Santaniemi
Pirjo Åström
Virpi Glumoff
Nora Pernaa
Ella-Noora Tallgren
Sanna Palosaari
Antti Nissinen
Meri Kaustio
Outi Kuismin
Janna Saarela
Katariina Nurmi
Kari K. Eklund
Mikko R. J. Seppänen
Timo Hautala
Publication date
09-03-2023
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 5/2023
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-023-01461-3

Other articles of this Issue 5/2023

Journal of Clinical Immunology 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.